Evidence map›Paper›PMID 27884083›Full record

ArticleGlobal public health2017

The globalisation strategies of five Asian tobacco companies: An analytical framework.

Kelley Lee, Jappe Eckhardt

Erratum issuedAbstract read
In one paragraph

Article in Global public health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Kelley Leea Faculty of Health Sciences , Simon Fraser University , Burnaby , BC , Canada.
Jappe Eckhardtb Department of Politics , University of York , York , UK.

Funding

Tobacco Companies, Public Policy and Global HealthR01CA091021 · NCI · U OF L LONDON SCH/HYGIENE &TROPICAL MED · PI LEE, KELLEY · 2001 to 2018
$5.1M
NCI NIH HHS R01 CA091021
6 · The paper itself

Abstract

With 30% of the world’s smokers, two million deaths annually from tobacco use, and rising levels of tobacco consumption, the Asian region is recognised as central to the future of global tobacco control. There is less understanding, however, of how Asian tobacco companies with regional and global aspirations are contributing to the global burden of tobacco-related disease and death. This introductory article sets out the background and rationale for this special issue on ‘The Emergence of Asian Tobacco Companies: Implications for Global Health Governance’. The article discusses the core questions to be addressed and presents an analytical framework for assessing the globalisation strategies of Asian tobacco firms. The article also discusses the selection of the five case studies, namely as independent companies in Asia which have demonstrated concerted ambitions to be a major player in the world market.

Indexed as

InternationalityAsiaCross-Cultural ComparisonGovernment AgenciesHumansMarketingOrganizational Case StudiesOwnershipPublic PolicyTobacco IndustryAsiaglobalisationtobacco controltobacco industrytransnational tobacco companies

Identifiers

PMID27884083
PMCPMC5553427

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.